Anti-infection treatment and pharmaceutical care for a patient with liver cirrhosis complicated with severe psittacosis
10.12173/j.issn.1005-0698.202506075
- VernacularTitle:1例肝硬化患者并发重症鹦鹉热的抗感染治疗分析与监护
- Author:
Baiqian XING
1
;
Hunan LIU
;
Yihong SUN
;
Nianfang LU
;
Zhongdong LI
Author Information
1. 首都医科大学电力教学医院(国家电网公司北京电力医院)药剂科(北京 100073)
- Publication Type:Journal Article
- Keywords:
Liver cirrhosis;
Chlamydia psittaci;
Omadacycline;
Voriconazole;
Posaconazole;
Pharmaceutical care
- From:
Chinese Journal of Pharmacoepidemiology
2025;34(11):1340-1346
- CountryChina
- Language:Chinese
-
Abstract:
This article presents the anti-infective treatment and pharmaceutical care of an elderly patient with liver cirrhosis complicated with severe psittacosis.Based on the pathophysiological characteristics of infection in patients with severe liver diseases and in combination with relevant guidelines,the combined regimen of omadacycline+moxifloxacin was adopted to treat psittacosis.In case of recurrent episodes,Aspergillus fumigata was detected in the metagenomic next-generation sequencing of bronchoalveolar lavage fluid.Initially,voriconazole was administered for treatment,and later switched to posaconazole.Additionally,clinical pharmacists provided pharmaceutical care encompassing adverse reaction monitoring and voriconazole therapeutic drug monitoring.The patient's infection was effectively controlled,body temperature returned to normal,white blood cell counts and platelet counts basically returned to normal range,serum high-sensitive C-reactive protein,procalcitonin,and other inflammatory indicators significantly decreased,and the patient was discharged.Clinical pharmacists assisted clinicians in formulating a reasonable anti-psittacosis treatment plan and provided individualized pharmaceutical care to ensure the effectiveness and safety of clinical drug treatment.
